Welcome to the May Life Science Update

The Life Science Update for Librarians is an initiative from NPG Communications, aiming to reduce all your life science e-communications from Nature Publishing
Group into one monthly installment.

We will keep you up-to-date with the latest news from our life science portfolio:
including promotional tools, news on open access periods, new launches,
special focus issues and much more

Read on to discover more. Featured products and subject areas within this
life science update include:

› Palgrave Macmillan’s Bio Science journals now available
› New life science journals from Asian societies join NPG
› Introducing SciBX
› Biotechnology & Pharmacology
› Cancer
› Immunology
› Molecular & cell biology
› Neuroscience

Find out the results of this poll in the June Life Science Update.

Last month’s question:  In the last 12 months, have you added any STM journals to your library in print format?

- what was the response?  55% said yes, 45% said no.

We are please to introduce three Palgrave Macmillan titles which are now available as part of the NPG site license portfolio.

Nature Publishing Group (NPG) is pleased to announce five new co-publishing agreements for 2009 in Japan and China. These developments are a landmark in Nature Publishing Group's strategy to expand its publishing operations across the Asia-Pacific region. The new journals will join the NPG portfolio from 2009 and more information will soon be available from your NPG sales representative.

Acta Pharmacologica Sinica: Shanghai Institute of Materia Medica
Asian Journal of Andrology: Shanghai Jiao Tong University
Hypertension Research: Japanese Society of Hypertension
Journal of Antibiotics: Japanese Antibiotics Research Association
Journal of Human Genetics: Japanese Society for Human Genetics

Find out more here
www.nature.com/press_releases/copublish.pdf

New from NPG, Science Business Exchange (SciBX) is a must read publication for Offices of Technology Transfer and all academic and corporate scientists and executives interested in enhancing the commercialization of life science. SciBX provides a timely, comprehensive and understandable analysis of the most commercially promising science and technology and enhances the efficiency and speed of transfer of science from bench to bedside.

Find out more here or contact your local sales representative for more information

Clinical Pharmacology & Therapeutics

Invest in the future of science and your institution with a site license to Clinical Pharmacology & Therapeutics (CPT). Recognized as the authoritative cross-disciplinary journal in experimental and clinical pharmacology, CPT is ranked in the top 5 percent of pharmacology journals*.  The journal has been featured online at Newsday.com, The Post-Standard and The Columbus Dispatch for its contributions to the science community.  Request a free site license trial and see what the buzz is all about.

REQUEST A FREE TRIAL – Clinical Pharmacology & Therapeutics

MORE INFORMATION ABOUT BIOTECHNOLOGY & PHARMACOLOGY PRODUCTS: CLICK HERE

Molecular Cancer Diagnostics (Nature Insight)

A key priority in translational cancer research is the discovery of molecular biomarkers that improve the early diagnosis of cancer and guide cancer prognosis, including the design and assessment of new therapeutic avenues. This Nature Insight highlights key approaches for the discovery and validation of cancer biomarkers, at the level of DNA, RNA and protein analysis. It also focuses on non-invasive imaging tools and serum analyses that will be important in detecting tumours and monitoring the course of cancer therapy.

Read the Insight in the April 3rd issue of Nature or access it free online for six months at: www.nature.com/nature/supplements/insight/canerdiagnostics/

Produced with support from

Critical Issues in Cancer and Nutrition

Nestle Science and Research, encompassing the Nestle Research Center, scientific development centers and an extensive network of external alliances, forms the most active, dynamic and successful translational science engine in global nutrition research. Scientists at the Nestle Research Center are actively pursuing answers to critical research questions surrounding cancer and nutrition

MORE INFORMATION ABOUT CANCER PRODUCTS CLICK HERE

Nature Immunology
FOCUS ON NATURAL KILLER CELLS

Natural killer cells influence immune responses to tumors, infections and pregnancy. Nature Immunology presents a series of specially commissioned articles that focus on natural killer cells and their far-reaching effects on diverse cell types and biological responses. The web focus, free for six months, also includes highlights of recent research findings, an annotated list of classic articles and links to selected NPG papers pertinent to this field.

For more information visit: www.nature.com/ni/focus/nkcells/

MORE INFORMATION ABOUT IMMUNOLOGY PRODUCTS: CLICK HERE

Special Web Focus from Cell Research:
DNA Damage Responses and Genome Maintenance

This web focus encompasses a collection of review and research articles that outline the current understanding of the genome maintenance systems involved in DNA damage detection, signaling, response and repair. Topics covered, include: DNA replication, excision repair, recombination, DNA damage tolerance, transcription-coupled repair, mismatch repair and genomic instability and cancer.

View this FREE web focus today

Special Issue from Cell Death & Differentiation:
Biology of hypoxia-inducible factors

CDD presents ‘Biology of hypoxia-inducible factors’ as the third instalment to the Special Issues collection.  This issue on hypoxia features 10 select Review articles FREE of charge focusing on the regulators and biological consequences of HIF activation.  View CDD’s Special Issues online at: www.nature.com/cdd/special.

MORE INFORMATION ABOUT MOLECULAR & CELL BIOLOGY PRODUCTS: CLICK HERE

Nature Reviews Neuroscience
Poster on Alzheimer’s disease: Amyloid-β and tau in Alzheimer’s disease

Two key proteins — amyloid-β and tau — are thought to contribute to neurodegeneration in Alzheimer’s disease (AD): directly, through the neurotoxic effects of their accumulation in the brain, and indirectly, through the loss of their normal functions.

This poster by Frank LaFerla provides up-to-date information on the interlinked signalling pathways associated with amyloid-β and tau, the contribution of these two proteins to AD pathology, and current and potential drug targets for the treatment of AD.

To view this poster online, visit: www.nature.com/nrn/posters/ad/index.html

MORE INFORMATION ABOUT NEUROSCIENCE PRODUCTS: CLICK HERE

This e-update is designed to keep you aware of news about NPG's life science portfolio.
Please let us know if you have any comments or suggestions to improve this
communication, or if you wish to unsubscribe to the Life Science Update for Librarians.

p.wong@nature.com

*Journal Citation Reports, Thomson, 2007

Your email address is in the NPG communications mailing list.  The Life Science Update for Librarians is part of NPG communications.

To unsubscribe to the Life Science Update for Librarians please e-mail: life_science_update.unsubscribe@info.nature.com

To unsubscribe to all e-communications for librarians from NPG, please e-mail: slbu.comms.unsubscribe@info.nature.com

For further technical assistance, please contact: institutions@nature.com

For other enquiries, please contact: feedback@nature.com

Nature Publishing Group | 75 Varick St Fl 9 | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London • Paris • Munich • New Delhi • Tokyo • Melbourne • San Diego • San Francisco •
Washington • New York • Boston • Hong Kong • Gurgaon • Mexico City • Basingstoke

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2008 Nature Publishing Group